Table 2. Patient demographics, verification criteria, multidrug-resistant tuberculosis results, HIV status, receipt of directly observed therapy, and therapy completion in <1 y for reported tuberculosis case cohorts, 1993–1997 and 2011–2015*.
| Variable | 1,272 Reported cases, 1993–1997 no. (%) patients | 266 Reported cases, 2011–2015 no. (%) patients |
|---|---|---|
| Age, y | ||
| 0–4 | 39 (3) | 0 |
| 5–14 | 10 (1) | 0 |
| 15–24 | 60 (5) | 13 (5) |
| 25–44 | 449 (35) | 66 (25) |
| 45–64 | 347 (27) | 112 (42) |
| >65 | 278 (22) | 73 (27) |
| Not available |
89 (7) |
2 (1) |
| M |
869 (68) |
188 (71) |
| F |
403 (32) |
78 (29) |
| Origin of birth | ||
| United States | 1,210 (95) | 222 (83) |
| Other than United States | 58 (5) | 44 (17) |
| Not available |
4 (<1) |
0 (0) |
| Verification criteria | ||
| Positive culture | 1,090 (86) | 225 (85) |
| Clinical case definition | 82 (6) | 14 (5) |
| Provider diagnosis | 70 (6) | 26 (10) |
| Positive smear/tissue | 30 (2) | 0 () |
| Not available |
0 () |
1 (<1) |
| Multidrug-resistant tuberculosis | ||
| Yes | 24 (2) | 6 (2) |
| No | 753 (59) | 210 (79) |
| Not applicable or available |
495 (39) |
50 (19) |
| HIV status | ||
| Positive | 386 (30) | 46 (17) |
| Negative | 292 (23) | 199 (75) |
| Not reported |
594 (47) |
21 (8) |
| Directly observed therapy | ||
| Direct only | 253 (20) | 134 (50) |
| Self only | 807 (63) | 63 (24) |
| Both | 25 (2) | 5 (2) |
| Not applicable or available |
187 (15) |
64 (24) |
| Therapy completed in <1 y | ||
| Yes | 604 (47) | 140 (53) |
| No | 113 (9) | 6 (2) |
| Not applicable or not available | 555 (44) | 120 (45) |